Global Pharma

What Global Pharma does

Global Pharma Healthcare Private Limited is a Chennai, India-based B2B pharmaceutical manufacturer and exporter founded in 1999 by doctors. The company produces 450+ pharmaceutical formulations across multiple dosage forms, including tablets, capsules, injectables, eye and ear drops, ointments, liquid orals, sachets, and nutraceuticals, spanning 25+ therapeutic segments. Its technical capability rests on a 75,000+ sq. ft. manufacturing facility in Chennai/Alathur that is 100% solar-powered via a 1.2 MW plant and operates with zero liquid discharge. The company is vertically integrated through a sister active pharmaceutical ingredient (API) manufacturing entity, allowing it to control upstream supply and capture additional margin. It holds DSIR approval for in-house R&D and maintains consumer-facing sub-brands including RichVit, Fizzvit, Ciprogen, and Glozyme.

The company has accumulated 700+ product registrations and 20+ Ministry of Health site visit approvals across export markets, underpinned by EU GMP, WHO GMP, and a comprehensive ISO suite (9001:2015 quality, 14001:2015 environmental, 45001:2018 safety, 22000:2005 food safety, 17025:2005 lab competence). These certifications enable participation in regulated institutional and government tenders across Asia, Africa, CIS, Europe, Latin America, the UK, and the Middle East.

The business model is B2B export-oriented. Revenue is generated through pharmaceutical product sales and contract manufacturing partnerships, with customer segments comprising government health ministries, healthcare providers, international distributors, and contract manufacturing partners across 40+ countries. The company is privately held and doctor/family-owned, with no disclosed external capital raises to date, indicating an organic-growth operating model.

Name

Global Pharma

Legal name

Global Pharma Healthcare Private Limited

Website

https://global-pharma.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

11–50 employees

Short description

Global Pharma Healthcare is a Chennai-based B2B pharmaceutical manufacturer producing 450+ formulations across tablets, capsules, injectables, and other dosage forms for governments, healthcare providers, distributors, and contract manufacturing partners across 40+ countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical and Medicine Manufacturing (32541), Medicinal and Botanical Manufacturing (325411), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industries

Generic APIs & Intermediates (Active Ingredients) (HLAIABAG), Specialty Pharmaceutical Distributors (HLAIAJAB), Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)

Keywords

• Pharmaceutical manufacturing
• Finished formulations
• Contract manufacturing
• Active pharmaceutical ingredients
• Nutraceutical products

Headquarters

HQ city

Chennai

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Finished Pharmaceutical Formulations Export: Global Pharma manufactures and exports a diverse portfolio of 450+ pharmaceutical solutions across 40+ countries, generating revenue through direct product sales to international distributors, healthcare providers, and government procurement channels. The company holds 700+ product registrations globally, enabling recurring revenue from established market relationships.
2. Contract Manufacturing Partnerships: End-to-end pharmaceutical manufacturing solutions from formulation and scale-up to validation and commercial production, tailored to enable market success for pharmaceutical partners. Revenue is generated through project-based and commercial supply contracts.
3. Active Pharmaceutical Ingredients (APIs): High-purity APIs manufactured in EU GMP certified facilities to multicompendial standards, sold as raw materials to pharmaceutical formulations manufacturers.
4. Nutraceuticals & OTC Products: Science-backed health supplements and OTC dermatological and wound care products sold in customizable packaging to distributors and retail channels.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

Global Pharma Healthcare manufactures and exports a diverse portfolio of 450+ finished pharmaceutical formulations across 40+ countries, spanning tablets, capsules, injectables, eye/ear drops, ointments, liquid orals, sachets, and nutraceuticals. The company also produces Active Pharmaceutical Ingredients (APIs) through vertical integration with a sister company and offers end-to-end contract manufacturing services from formulation development through validation and commercial production.

Product overview

Global Pharma Healthcare is a pharmaceutical manufacturing company founded in 1999, offering an extensive portfolio of finished dosage forms across multiple categories including tablets, capsules, liquid orals, topical preparations (ointments and creams), eye/ear drops, and parenterals (small and large volume). The product portfolio spans over 25 therapeutic segments covering Cardiovascular Drugs, Anti-Diabetics Agents, Antibiotics, NSAIDs, Anti-Malarials, Anti-Ulcerants, Anti-Psychotics, Anti-TB Agents, and more. The company also produces nutritional supplements, nutraceuticals, and medical devices. Manufacturing capabilities are complemented by contract manufacturing partnerships and global regulatory and market access services. Through vertical integration with a sister company's API manufacturing facility, Global Pharma ensures supply reliability and quality from raw materials to finished formulations across 40+ countries.

Differentiator

Problem solved

Functional benefit

Brands

• RichVit: Vitamin and nutritional supplement product line
• Fizzvit
• Ciprogen
• Glozyme

Products and services

• Liquid Orals

Quantifiable outcome

• 450+ pharmaceutical solutions exported to 40+ countries
• +4 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Sister Company (API Manufacturing)coreStrategic or Co-development PartnerThrough a sister company specializing in Active Pharmaceutical Ingredient (API) manufacturing, Global Pharma achieves vertical integration from raw materials to finished formulations. This partnership ensures reliable supply, cost efficiency, and consistent quality throughout the value chain, strengthening supply reliability for pharmaceutical partners and patients worldwide.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Glenmark Pharmaceuticals: Indian-headquartered generic and specialty manufacturer with global commercial footprint spanning emerging markets and regulated geographies. Comparable on generic formulations, dosage-form diversity, and international regulatory positioning.
• Cipla: India-headquartered global generic pharmaceutical manufacturer exporting to 80+ countries across emerging and developed markets. Highly comparable to Global Pharma across finished formulations, therapeutic breadth, and government/MOH procurement channels; operates at materially larger scale.
• Sun Pharmaceutical Industries: India's largest specialty and generic pharma manufacturer with global manufacturing footprint and broad product portfolio. Highly comparable on generic formulations, dosage-form diversity, and multinational distribution; significantly larger.
• Zydus Lifesciences (Cadila Healthcare): Indian vertically integrated generic manufacturer with API and finished-dose operations and global registrations. Comparable to Global Pharma on integration model, dosage-form breadth, and emerging-market presence.
• Lupin Limited: Indian generic pharmaceutical manufacturer with strong emerging-market and regulated-market exposure. Comparable to Global Pharma on formulation portfolio, API operations, and global regulatory approvals across multiple therapeutic segments.
• Strides Pharma Science: Indian generic pharmaceutical manufacturer focused on soft-gel, oral solids, and injectable products with heavy emerging-market and institutional procurement orientation. Closest in scale and emerging-market emphasis among Indian peers.
• Aurobindo Pharma: Largest Indian generic formulations and API exporter with US/Europe/emerging-market reach. Comparable to Global Pharma on dosage-form breadth (oral solids, injectables, sterile), API+formulation integration, and global regulatory portfolio — but at a substantially larger scale.
• Dr. Reddy's Laboratories: Indian-headquartered multinational generic and API manufacturer with strong presence in emerging markets and regulated markets. Comparable across therapeutic breadth, API+formulation model, and global regulatory footprint.
• Ipca Laboratories: Indian generic manufacturer with vertically integrated API operations and global presence across anti-malarials, anti-rheumatics, and other therapeutic areas. Comparable to Global Pharma on API+formulation integration and emerging-market focus.
• Emcure Pharmaceuticals: Indian vertically integrated pharmaceutical company combining API manufacturing, finished formulations, and biopharmaceuticals with strong emerging-market presence. Comparable to Global Pharma on API integration, broad therapeutic portfolio, and global exports.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/globalpharmaind
• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/global-pharma-healthcare-ltd.

Compliance15 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Global Pharma